Cited 2 time in
Coexistence of chronic myeloid leukemia and pulmonary plasmacytoma mimicking primary lung cancer
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kim, Hee Jin | - |
| dc.contributor.author | Kim, Moon Jin | - |
| dc.contributor.author | Lee, Min Jeong | - |
| dc.contributor.author | Ahn, Jong-Hwa | - |
| dc.contributor.author | Kim, Ho-Su | - |
| dc.contributor.author | Kim, In-Suk | - |
| dc.contributor.author | Lee, Jong Sil | - |
| dc.contributor.author | Lee, Gyeong-Won | - |
| dc.date.accessioned | 2022-12-27T04:04:27Z | - |
| dc.date.available | 2022-12-27T04:04:27Z | - |
| dc.date.issued | 2010-11 | - |
| dc.identifier.issn | 0925-5710 | - |
| dc.identifier.issn | 1865-3774 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/24893 | - |
| dc.description.abstract | A 61-year-old man was diagnosed with the simultaneous occurrence of chronic myeloid leukemia (CML) and infiltrative intrathoracic plasmacytoma, radiologically mimicking bronchogenic carcinoma. Following the administration of imatinib mesylate (IM; 400 mg/day), both hematologic and partial cytogenetic remission of CML were achieved. However, the pulmonary plasmacytoma was persistently aggravated. High-dose dexamethasone was added to the IM therapy because the patient refused radiotherapy to control the aggravated pulmonary plasmacytoma. Finally, he died due to pneumonia and multi-organ failure during concurrent administration of IM and high-dose dexamethasone. | - |
| dc.format.extent | 4 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | SPRINGER JAPAN KK | - |
| dc.title | Coexistence of chronic myeloid leukemia and pulmonary plasmacytoma mimicking primary lung cancer | - |
| dc.type | Article | - |
| dc.publisher.location | 일본 | - |
| dc.identifier.doi | 10.1007/s12185-010-0705-7 | - |
| dc.identifier.scopusid | 2-s2.0-78549244401 | - |
| dc.identifier.wosid | 000285157800013 | - |
| dc.identifier.bibliographicCitation | INTERNATIONAL JOURNAL OF HEMATOLOGY, v.92, no.4, pp 651 - 654 | - |
| dc.citation.title | INTERNATIONAL JOURNAL OF HEMATOLOGY | - |
| dc.citation.volume | 92 | - |
| dc.citation.number | 4 | - |
| dc.citation.startPage | 651 | - |
| dc.citation.endPage | 654 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Hematology | - |
| dc.relation.journalWebOfScienceCategory | Hematology | - |
| dc.subject.keywordPlus | MULTIPLE-MYELOMA | - |
| dc.subject.keywordPlus | IMATINIB MESYLATE | - |
| dc.subject.keywordPlus | PATIENT | - |
| dc.subject.keywordAuthor | Leukemia | - |
| dc.subject.keywordAuthor | Myeloid | - |
| dc.subject.keywordAuthor | Chronic phase | - |
| dc.subject.keywordAuthor | Plasmacytoma | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
